Correction to: Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience.

Huang, Hong-Feng; Zhou, Jing-Yi; Xie, Wen-Qing; Wu, Jian-Yong; Deng, Hao; Chen, Jiang-Hua

Huang, Hong-Feng; Zhou, Jing-Yi; Xie, Wen-Qing; Wu, Jian-Yong; Deng, Hao; Chen, Jiang-Hua.

Afiliação

Huang HF; Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Qingchun Road 79, Hangzhou, 310003, China.
Zhou JY; Key Laboratory of Nephropathy, Hangzhou, Zhejiang Province, China.
Xie WQ; Kidney Disease Immunology Laboratory, The Third Grade Laboratory, State Administration of Traditional Chinese Medicine of China, Hangzhou, 310003, China.
Wu JY; Key Laboratory of Multiple Organ Transplantation, Ministry of Health of China, Beijing, China.
Deng H; Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Qingchun Road 79, Hangzhou, 310003, China.
Chen JH; Key Laboratory of Nephropathy, Hangzhou, Zhejiang Province, China.

Int Urol Nephrol ; 51(3): 559, 2019 Mar.

Article em En | MEDLINE | ID: mdl-30666493

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int Urol Nephrol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google